Concepedia

Daniel Rycroft

DR

Statistics

Publications

4

Citations

107

H-Index

4

Active since

2011

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Daniel Rycroft is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, targeted cancer therapy, and molecular oncology.

Publications per year

2011–2021

4

Publications

4

A dual‐targeting antibody against EGFR‐VEGF for lung and head and neck cancer treatment

Hongzheng Zhang, Sujin Yun, Thil Batuwangala et al. · International Journal of Cancer · 2011 · 34 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth

Heather L. Jackson, David Granger, Gavin C. Jones et al. · Molecular Cancer Research · 2016 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +16

Antibody Afucosylation Augments CD16-Mediated Serial Killing and IFNγ Secretion by Human Natural Killer Cells

Alexandros Karampatzakis, Petr Brož, Camille Rey et al. · Frontiers in Immunology · 2021 · 28 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension

Laura Goodall, Milan Ovečka, Daniel Rycroft et al. · PLoS ONE · 2015 · 17 citations · Full text

Medicine, Immunology, Pharmacology +17

1–4 of 4